Cargando…
Potential of multiomics technology in precision medicine
The ‘precision medicine’ refers to the generation of identification and classification criteria for advanced taxonomy of patients, exploiting advanced models to infer optimized clinical decisions for each disease phenotype. RECENT FINDINGS: The current article reviews new advances in the past 18 mon...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6818999/ https://www.ncbi.nlm.nih.gov/pubmed/31464810 http://dx.doi.org/10.1097/MOG.0000000000000589 |
_version_ | 1783463660162646016 |
---|---|
author | Putignani, Lorenza Gasbarrini, Antonio Dallapiccola, Bruno |
author_facet | Putignani, Lorenza Gasbarrini, Antonio Dallapiccola, Bruno |
author_sort | Putignani, Lorenza |
collection | PubMed |
description | The ‘precision medicine’ refers to the generation of identification and classification criteria for advanced taxonomy of patients, exploiting advanced models to infer optimized clinical decisions for each disease phenotype. RECENT FINDINGS: The current article reviews new advances in the past 18 months on the microbiomics science intended as new discipline contributing to advanced ‘precision medicine’. Recently published data highlight the importance of multidimensional data in the description of deep disease phenotypes, including microbiome and immune profiling, and support the efficacy of the systems medicine to better stratify patients, hence optimizing diagnostics, clinical management and response to treatments. SUMMARY: The articles referenced in this review help inform the reader on new decision-support systems that can be based on multiomics patients’ data including microbiome and immune profiling. These harmonized and integrated data can be elaborated by artificial intelligence to generate optimized diagnostic pipelines and clinical interventions. |
format | Online Article Text |
id | pubmed-6818999 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-68189992019-11-26 Potential of multiomics technology in precision medicine Putignani, Lorenza Gasbarrini, Antonio Dallapiccola, Bruno Curr Opin Gastroenterol IMMUNOLOGY: Edited by Alan C. Moss The ‘precision medicine’ refers to the generation of identification and classification criteria for advanced taxonomy of patients, exploiting advanced models to infer optimized clinical decisions for each disease phenotype. RECENT FINDINGS: The current article reviews new advances in the past 18 months on the microbiomics science intended as new discipline contributing to advanced ‘precision medicine’. Recently published data highlight the importance of multidimensional data in the description of deep disease phenotypes, including microbiome and immune profiling, and support the efficacy of the systems medicine to better stratify patients, hence optimizing diagnostics, clinical management and response to treatments. SUMMARY: The articles referenced in this review help inform the reader on new decision-support systems that can be based on multiomics patients’ data including microbiome and immune profiling. These harmonized and integrated data can be elaborated by artificial intelligence to generate optimized diagnostic pipelines and clinical interventions. Lippincott Williams & Wilkins 2019-11 2019-09-10 /pmc/articles/PMC6818999/ /pubmed/31464810 http://dx.doi.org/10.1097/MOG.0000000000000589 Text en Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 |
spellingShingle | IMMUNOLOGY: Edited by Alan C. Moss Putignani, Lorenza Gasbarrini, Antonio Dallapiccola, Bruno Potential of multiomics technology in precision medicine |
title | Potential of multiomics technology in precision medicine |
title_full | Potential of multiomics technology in precision medicine |
title_fullStr | Potential of multiomics technology in precision medicine |
title_full_unstemmed | Potential of multiomics technology in precision medicine |
title_short | Potential of multiomics technology in precision medicine |
title_sort | potential of multiomics technology in precision medicine |
topic | IMMUNOLOGY: Edited by Alan C. Moss |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6818999/ https://www.ncbi.nlm.nih.gov/pubmed/31464810 http://dx.doi.org/10.1097/MOG.0000000000000589 |
work_keys_str_mv | AT putignanilorenza potentialofmultiomicstechnologyinprecisionmedicine AT gasbarriniantonio potentialofmultiomicstechnologyinprecisionmedicine AT dallapiccolabruno potentialofmultiomicstechnologyinprecisionmedicine |